Display Settings:

Format

Send to:

Choose Destination
    J Biomed Inform. 2007 Feb;40(1):47-54. Epub 2006 Mar 15.

    Status of clinical gene sequencing data reporting and associated risks for information loss.

    Source

    Department of Health Management and Informatics, University of Missouri, 324 Clark Hall, Columbia, MO 65211, USA. Doug@InfoTechMD.com <Doug@InfoTechMD.com>

    Abstract

    Clinical gene sequencing is growing in importance and cost-effectiveness. In the past two years, the number of genes associated with disease has grown by roughly 25%. Knowledge of genetic variations will soon guide drug selection and dosages, predict risks from toxin exposures, and inform nutritional needs. Despite the significance of sequencing, methods for reporting results are problematic. Frequent use of paper and infrequent use of naming standards impede data exchange and make incorporation into the electronic medical record difficult. Reports often describe only variations found, rather than all data (all patient bases sequenced). Also, reports frequently do not describe reference data used to define variations. These practices create risks for loss of both data and information. Standardized electronic reporting of all data (all bases sequenced and all reference data) and electronic record systems capable of storing these results would both prevent data loss and simplify the preservation of information those data provide.

    PMID:
    16617035
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk